[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fwgpUtR4WgMn__UvFSVQ6QO4ZgrwDT7VF5KCW-UArCfY":8,"$fsGUDJTqAYnuyHTELWdUkek7QCc1m-GJkh-ShFXeJTn8":55,"$fGaTSYyyM5w0WejnZFLAoG4oVAIaBjLivL0GjZJOXtRA":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},65529,863254,[],"https://ystcdn.venuertc.com/medical/ystApp/Dlmj9URvs7gXdepZpARivDbqwZwkg06p.png","朱永亮","龙口南山养生谷肿瘤医院","放射科","住院医师",397,0,"直肠癌晚期治疗用药指南：关注药品安全细节","","https://ystcdn.venuertc.com/venue/AI/33d2669d-e49f-4ce7-98e6-2d5e6e066dad.jpg","\u003Cdiv class=\"material-container\">\n  \u003Ch2 id=\"material_title\" class=\"material-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">直肠癌晚期治疗用药指南：关注药品安全细节\u003C/h2>\n  \u003Cdiv class=\"material-subsection material-cover-1\">\n    \u003Ch2 class=\"material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 药物类别与主要用途简介 🌱\u003C/h2>\n    \u003Cdiv class=\"material-p\">\n      说起来，直肠癌晚期治疗的药物种类不少，主要包含化疗药物、靶向药、生物制剂等。各种药品各有专长，比如阻断肿瘤细胞分裂、抑制血管新生，或通过免疫途径发挥作用。这篇用药指引，将介绍7个核心细节，帮助你避开常见误区，合理用药，提升治疗安全性与效果。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-subsection material-cover-2\">\n    \u003Ch2 class=\"material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 药物作用机制拆解\u003C/h2>\n    \u003Cdiv class=\"material-p\">\n      \u003Cspan class=\"material-mark\">化疗药物\u003C/span>（如奥沙利铂、伊立替康、氟尿嘧啶等）通常通过干扰细胞DNA合成或分裂来抑制肿瘤细胞生长。\n      \u003Cspan class=\"material-mark\">靶向药物\u003C/span>（贝伐珠单抗等）可以阻断肿瘤新生血管供应，限制肿瘤扩张。\n      \u003Cspan class=\"material-mark\">免疫治疗药\u003C/span>则激活自身免疫系统，有针对性地识别与清除异常细胞。\n      这些机制只影响药物如何发生作用，不涉及具体用药步骤。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-subsection material-cover-3\">\n    \u003Ch2 class=\"material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 剂型与服用技巧 🟦🟧\u003C/h2>\n    \u003Cdiv class=\"material-p\">\n      药物剂型包括\u003Cspan class=\"material-mark\">注射液、片剂、胶囊\u003C/span>等。例如，部分氟尿嘧啶类药物为\u003Cspan class=\"material-mark\">静脉注射\u003C/span>，服用时通常在专科医生指导下进行。\u003Cspan class=\"material-mark\">卡培他滨片\u003C/span>则为口服，用温水吞服，避免嚼碎。遇到肠溶片或缓释制剂，不要掰开或碾碎，以免影响药效。服药时建议喝足量温水（约200ml）以助吸收。\n    \u003C/div>\n    \u003Cdiv class=\"material-tip\">\n      \u003Cspan class=\"material-emoji\">💡\u003C/span>\n      \u003Cspan>正确做法：\u003C/span>按医生指示足量饮水吞服，不自行增减剂量或更改服用方式。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-subsection material-cover-4\">\n    \u003Ch2 class=\"material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 用药时间与方法要点\u003C/h2>\n    \u003Cdiv class=\"material-p\">\n      口服药物（如卡培他滨）一般建议餐后30分钟内服用，有助于降低消化道反应。静脉给药（如奥沙利铂、伊立替康）通常由专业人员操作，按疗程周期安排。部分靶向药（如贝伐珠单抗）为滴注方式，滴注时长约30-90分钟不等。\n    \u003C/div>\n    \u003Cdiv class=\"material-tip\">\n      \u003Cspan class=\"material-emoji\">⏰\u003C/span>\n      \u003Cspan>需要注意：\u003C/span>避免空腹用药，遵守规定疗程，不要漏服或随意加量。\n    \u003C/div>\n    \u003Cdiv class=\"material-p material-case\">\n      有位患者使用口服化疗药时将药片碾碎，出现了胃部刺激症状。强调：特殊剂型如肠溶片千万不能擅自损坏药片完整性。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-subsection material-cover-5\">\n    \u003Ch2 class=\"material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 药物相互作用如何规避 🔄\u003C/h2>\n    \u003Cdiv class=\"material-p\">\n      治疗晚期直肠癌常常联合多种药物，但部分药物之间可能存在\u003Cspan class=\"material-mark\">相互作用\u003C/span>。例如，\u003Cspan class=\"material-mark\">贝伐珠单抗\u003C/span>与部分抗高血压药同用容易增加血压升高风险。\u003Cspan class=\"material-mark\">伊立替康\u003C/span>不宜与强抑制肝脏酶的药物联用，否则易导致毒性反应。\u003Cspan class=\"material-mark\">氟尿嘧啶\u003C/span>与华法林等抗凝药物同用，经常需要严密监测凝血指标。\n    \u003C/div>\n    \u003Cdiv class=\"material-tip\">\n      \u003Cspan class=\"material-emoji\">⚠️\u003C/span>\n      \u003Cspan>特别提醒：\u003C/span>用药期间主动告知医生自己所有用药历史（包括非处方药及保健品），切勿自行调整用药组合。\n    \u003C/div>\n    \u003Cdiv class=\"material-p material-case\">\n      临床上使用贝伐珠单抗与抗凝药合用时，出现凝血异常，需减量处理。这说明与其他药物联用一定要小心，并及时监测相关指标。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-subsection material-cover-6\">\n    \u003Ch2 class=\"material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 特殊人群用药调整 🚻\u003C/h2>\n    \u003Cdiv class=\"material-p\">\n      老年患者常因肝肾功能减退需适当减量，初次用药建议从低剂量起。儿童和孕妇一般不推荐使用绝大多数抗肿瘤化疗药物。如需用药，须严格遵医嘱。肝损伤患者（如转氨酶显著升高）用药时需要评估肝脏耐受力，部分药物（如伊立替康）剂量应谨慎调整。\n    \u003C/div>\n    \u003Cdiv class=\"material-tip\">\n      \u003Cspan class=\"material-emoji\">🔎\u003C/span>\n      \u003Cspan>正确做法：\u003C/span>有肝肾功能异常者务必告知医生，以获个体化剂量调整。\n    \u003C/div>\n    \u003Cdiv class=\"material-p material-case\">\n      一位老年患者调整卡培他滨剂量后，降低了不良反应发生率，显示适当减量可改善耐受性。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-subsection material-cover-7\">\n    \u003Ch2 class=\"material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 常见不良反应及处理方法\u003C/h2>\n    \u003Cdiv class=\"material-p\">\n      \u003Cspan class=\"material-mark\">化疗药物\u003C/span>不良反应包括中性粒细胞减少、贫血、恶心与消化道反应；\u003Cspan class=\"material-mark\">靶向药物\u003C/span>常见高血压、出血倾向等风险；\u003Cspan class=\"material-mark\">免疫治疗\u003C/span>可能导致肌肉关节不适或皮疹。\n      \u003Cspan class=\"material-stat\">临床研究数据显示，联合用药方案中位生存期可达10.8个月，但中性粒细胞减少发生率升高（Tabernero et al., 2023）。\u003C/span>\n    \u003C/div>\n    \u003Cdiv class=\"material-tip\">\n      \u003Cspan class=\"material-emoji\">🩺\u003C/span>\n      \u003Cspan>需要注意：\u003C/span>若出现发热、皮肤异常或严重不适，建议立即联系医生。部分不良反应需通过暂停、减量或对症处理加以缓解。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-subsection material-cover-8\">\n    \u003Ch2 class=\"material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 储存条件和药品有效期 ⏳\u003C/h2>\n    \u003Cdiv class=\"material-p\">\n      抗肿瘤药品多为生物制剂或活性分子，对储存环境要求较高。大部分药品需\u003Cspan class=\"material-mark\">避光、密封、低温保存（一般2-8℃）\u003C/span>，不可冷冻。口服药如卡培他滨、曲氟尿苷等，应置于干燥、阴凉处。已开封药物请按包装要求及时用完，超过有效期或出现异常外观请勿继续使用。\n    \u003C/div>\n    \u003Cdiv class=\"material-tip\">\n      \u003Cspan class=\"material-emoji\">❄️\u003C/span>\n      \u003Cspan>正确做法：\u003C/span>药品储存在原包装中，远离儿童和易受污染场所。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-subsection material-cover-9\">\n    \u003Ch2 class=\"material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 漏服与过量处理建议\u003C/h2>\n    \u003Cdiv class=\"material-p\">\n      遇到漏服时，不可自行补加双倍剂量。若临近下次服药时间，可直接跳过漏服部分。一次误服过量，应尽快就医处理，并带上药品包装。部分特殊药品如贝伐珠单抗为医院滴注，基本不发生漏服问题，但静脉注射过量时需密切监控不良反应。\n    \u003C/div>\n    \u003Cdiv class=\"material-tip\">\n      \u003Cspan class=\"material-emoji\">📞\u003C/span>\n      \u003Cspan>特别提醒：\u003C/span>如误服、错服、超量使用，应第一时间联系专业医务人员，切勿拖延。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-subsection material-cover-10\">\n    \u003Ch2 class=\"material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 关键用药案例总结\u003C/h2>\n    \u003Cdiv class=\"material-p\">\n      \u003Cul class=\"material-case-ul\">\n        \u003Cli>患者使用多种药物联合时出现中性粒细胞减少，经调整剂量后改善。\u003C/li>\n        \u003Cli>贝伐珠单抗与抗高血压药合用引发高血压，及时监测血压并调整方案。\u003C/li>\n      \u003C/ul>\n      这些实际经验提醒：多药联用下，密切监控身体反应尤为重要。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-subsection material-cover-11\">\n    \u003Ch2 class=\"material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">11 文献参考与权威数据\u003C/h2>\n    \u003Cdiv class=\"material-ref\">\n      \u003Cul>\n        \u003Cli>Tabernero, J., et al. (2023). \"Trifluridine-tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer (SUNLIGHT): a randomised, phase 3 trial.\" \u003Ci>Lancet Oncology\u003C/i>, 24(1), 91–104. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/36494251/\" target=\"_blank\">PubMed\u003C/a>\u003C/li>\n        \u003Cli>Van Cutsem, E., et al. (2020). \"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.\" \u003Ci>Annals of Oncology\u003C/i>, 31(10), 1291–1303. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/32853878/\" target=\"_blank\">PubMed\u003C/a>\u003C/li>\n        \u003Cli>Highlander, S.K., et al. (2022). \"Colorectal Cancer Treatment and Drug Safety.\" \u003Ci>Seminars in Oncology Nursing\u003C/i>, 38(5), 563–578. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/35313480/\" target=\"_blank\">PubMed\u003C/a>\u003C/li>\u003C/ul>\u003C/div>\u003C/div>\n\u003C/div>\n\u003Cstyle>\n.material-container {\n  max-width: 820px;\n  margin: 35px auto;\n  padding: 25px 28px 40px 28px;\n  background: #f6fbfa;\n  border-radius: 18px;\n  box-shadow: 0 6px 32px rgba(171,191,193,0.11);\n  font-family: \"PingFang SC\", \"Segoe UI\", Arial, \"Microsoft YaHei\", sans-serif;\n  color: #20444d;\n  line-height: 2em;\n  font-size: 18px;\n}\n.material-title {\n  font-size: 2.1em;\n  color: #194660;\n  text-align: center;\n  padding-bottom: 18px;\n  font-weight: 600;\n  letter-spacing: 0.1em;\n  border-bottom: 2px solid #d6ede5;\n}\n.material-subsection {\n  margin-top: 34px;\n  padding: 16px 14px 18px 18px;\n  border-radius: 13px;\n  background: linear-gradient(95deg,#f2fefd 0%,#e6eeef 100%);\n  box-shadow: 0 2px 8px rgba(137,180,152,0.08);\n}\n.material-h2 {\n  margin-top: -12px;\n  font-size: 1.25em;\n  margin-bottom: 12px;\n  color: #2d768d;\n  display: flex;\n  align-items: center;\n  font-weight: 500;\n  padding-bottom: 2px;\n}\n.material-p {\n  font-size: 1em;\n  margin-bottom: 12px;\n  padding-left: 6px;\n}\n.material-tip {\n  background: #ebfaf3;\n  border-left: 5px solid #89dbb2;\n  margin-top: 10px;\n  margin-bottom: 10px;\n  padding: 10px 18px 10px 16px;\n  border-radius: 7px;\n  font-size: 1em;\n  color: #16985a;\n  display: flex;\n  align-items: center;\n  line-height: 1.9em;\n}\n.material-tip .material-emoji {\n  margin-right: 7px;\n  font-size: 1.23em;\n  line-height: normal;\n}\n.material-case {\n  background: #f6e6e7;\n  border-left: 5px solid #e0708a;\n  padding: 8px 16px 8px 14px;\n  border-radius: 8px;\n  color: #b03030;\n  margin: 14px 0 0 0;\n}\n.material-mark {\n  background: #dcf0f1;\n  border-radius: 2px;\n  padding: 0 3px;\n  color: #1c709d;\n  margin: 0 2px;\n  font-weight: 500;\n}\n.material-stat {\n  display: inline-block;\n  color: #227c47;\n  background: #e1f6dc;\n  padding: 2px 8px;\n  border-radius: 4px;\n  font-size: 0.96em;\n  margin: 0 4px 0 4px;\n}\n.material-case-ul {\n  padding-left: 2em;\n  margin: 0 0 0.5em 0;\n}\n.material-cover-1 {background: linear-gradient(120deg, #fdfcf1 0%, #eaf2ef 80%);}\n.material-cover-2 {background: linear-gradient(110deg,#f5f8fc 0%,#e5f5fa 100%);}\n.material-cover-3 {background: linear-gradient(100deg,#f7fafd 0%,#f6fbfa 100%);}\n.material-cover-4 {background: linear-gradient(118deg,#fff7f5 0%,#edf1e9 100%);}\n.material-cover-5 {background: linear-gradient(90deg,#f6eefd 0%,#eaf7fd 100%);}\n.material-cover-6 {background: linear-gradient(96deg,#fdfbed 0%,#eaf8f6 90%);}\n.material-cover-7 {background: linear-gradient(104deg,#f6faef 0%,#edf7fa 100%);}\n.material-cover-8 {background: linear-gradient(115deg,#fdf6fa 0%,#eaf9ec 100%);}\n.material-cover-9 {background: linear-gradient(90deg,#d6ecff 0%,#e7faee 100%);}\n.material-cover-10 {background: linear-gradient(110deg,#f5f8fc 0%,#f5fafd 100%);}\n.material-cover-11 {background: linear-gradient(120deg,#f9fdef 0%,#eceefb 100%);}\n.material-ref {\n  font-size: 0.96em;\n  color: #24474e;\n  margin-top: 8px;\n  padding-left: 15px;\n}\n.material-ref ul {\n  padding-left: 22px;\n  margin-top: 0;\n  margin-bottom: 0;\n}\n.material-ref li {\n  margin-bottom: 7px;\n}\n.material-summary {\n  background: #f7f1ef;\n  border-left: 4px solid #db8797;\n  padding: 11px 15px 10px 22px;\n  color: #ba4055;\n  border-radius: 7px;\n  font-size: 1em;\n  margin-top: 28px;\n}\n.material-footer {\n  margin-top: 40px;\n  font-size: 1em;\n  letter-spacing: 0.03em;\n}\n@media screen and (max-width: 600px){\n  .material-container {\n    padding: 12px 7px 24px 7px;\n  }\n  .material-title{\n    font-size:1.2em;\n  }\n  .material-h2{\n    font-size:1.1em;\n  }\n}\n\u003C/style>\n\n","\u003Cdiv class=\"material-container\">\n  \u003Ch2 id=\"material_title\" class=\"material-title\" style=\"color: rgb(",557,"2025-09-03 09:24:04","直肠癌, 晚期治疗, 药物安全, 用药指南, 化疗药物, 靶向药物, 免疫治疗, 不良反应、防治","了解直肠癌晚期的治疗药物、用药安全要点及应对方案，专业指导提升治疗效果，确保安全用药，适合患者及家属阅读。","2025-09-08 11:54:17",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]